Charles E. Mahan

1.5k total citations
36 papers, 1.0k citations indexed

About

Charles E. Mahan is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Charles E. Mahan has authored 36 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Internal Medicine, 26 papers in Cardiology and Cardiovascular Medicine and 7 papers in Surgery. Recurrent topics in Charles E. Mahan's work include Venous Thromboembolism Diagnosis and Management (31 papers), Atrial Fibrillation Management and Outcomes (23 papers) and Acute Myocardial Infarction Research (9 papers). Charles E. Mahan is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (31 papers), Atrial Fibrillation Management and Outcomes (23 papers) and Acute Myocardial Infarction Research (9 papers). Charles E. Mahan collaborates with scholars based in United States, Canada and Germany. Charles E. Mahan's co-authors include Alex C. Spyropoulos, Allison Burnett, David García, Lynn B. Oertel, Sara R. Vazquez, Jack Ansell, Stefano Barco, John Fanikos, Matthew E. Borrego and Franco Piovella and has published in prestigious journals such as Blood, Stroke and The American Journal of Medicine.

In The Last Decade

Charles E. Mahan

36 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles E. Mahan United States 16 823 710 203 131 119 36 1.0k
Allison Burnett United States 11 670 0.8× 494 0.7× 186 0.9× 114 0.9× 86 0.7× 31 929
Lana A. Castellucci Canada 14 617 0.7× 587 0.8× 161 0.8× 131 1.0× 148 1.2× 48 900
N. Ruiz‐Giménez Spain 11 748 0.9× 615 0.9× 194 1.0× 113 0.9× 105 0.9× 19 845
Esteban Gándara Canada 16 718 0.9× 529 0.7× 196 1.0× 146 1.1× 180 1.5× 42 992
Ricardo Pavanello Brazil 9 990 1.2× 767 1.1× 316 1.6× 112 0.9× 127 1.1× 20 1.2k
Cynthia Wu Canada 17 834 1.0× 558 0.8× 239 1.2× 219 1.7× 115 1.0× 55 1.1k
Marica Perlati Italy 5 799 1.0× 486 0.7× 256 1.3× 137 1.0× 131 1.1× 6 972
Michela Giustozzi Italy 19 470 0.6× 511 0.7× 164 0.8× 72 0.5× 155 1.3× 51 895
B. Brandolin Italy 6 699 0.8× 401 0.6× 192 0.9× 154 1.2× 113 0.9× 8 877
Michele G. Beckman United States 14 902 1.1× 518 0.7× 264 1.3× 292 2.2× 112 0.9× 36 1.2k

Countries citing papers authored by Charles E. Mahan

Since Specialization
Citations

This map shows the geographic impact of Charles E. Mahan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles E. Mahan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles E. Mahan more than expected).

Fields of papers citing papers by Charles E. Mahan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles E. Mahan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles E. Mahan. The network helps show where Charles E. Mahan may publish in the future.

Co-authorship network of co-authors of Charles E. Mahan

This figure shows the co-authorship network connecting the top 25 collaborators of Charles E. Mahan. A scholar is included among the top collaborators of Charles E. Mahan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles E. Mahan. Charles E. Mahan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Collins, Curtis D., et al.. (2025). Performance measures for health-system pharmacy: Updated recommendations from the Pharmacy Accountability Measures Work Group. American Journal of Health-System Pharmacy. 82(21). e878–e891. 1 indexed citations
2.
Nisio, Marcello Di, Charles E. Mahan, Konstantinos Christodoulou, et al.. (2024). Epidemiology of deep vein thrombosis. VASA. 53(5). 298–307. 11 indexed citations
3.
Farmakis, Ioannis T., Stefano Barco, Anna C. Mavromanoli, et al.. (2022). Cost‐of‐Illness Analysis of Long‐Term Health Care Resource Use and Disease Burden in Patients With Pulmonary Embolism: Insights From the PREFER in VTE Registry. Journal of the American Heart Association. 11(20). e027514–e027514. 23 indexed citations
4.
Baugh, Christopher W., Michael P. Levine, Jason Wilson, et al.. (2019). Anticoagulant Reversal Strategies in the Emergency Department Setting: Recommendations of a Multidisciplinary Expert Panel. Annals of Emergency Medicine. 76(4). 470–485. 61 indexed citations
5.
Fanikos, John, et al.. (2017). Renal Function Considerations for Stroke Prevention in Atrial Fibrillation. The American Journal of Medicine. 130(9). 1015–1023. 37 indexed citations
6.
Kaatz, Scott, et al.. (2017). Management of Elective Surgery and Emergent Bleeding with Direct Oral Anticoagulants. Current Cardiology Reports. 19(12). 124–124. 19 indexed citations
7.
Fanikos, John, et al.. (2017). Renal Function and Direct Oral Anticoagulant Treatment for Venous Thromboembolism. The American Journal of Medicine. 130(10). 1137–1143. 7 indexed citations
8.
Mahan, Charles E., et al.. (2017). Venous thromboembolism: role of pharmacists and managed care considerations.. PubMed. 23(20 Suppl). S391–S398. 2 indexed citations
9.
Burnett, Allison, Charles E. Mahan, Sara R. Vazquez, et al.. (2016). Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment. Journal of Thrombosis and Thrombolysis. 41(1). 206–232. 222 indexed citations
10.
Burnett, Allison, et al.. (2016). Heparin-induced thrombocytopenia: reducing misdiagnosis via collaboration between an inpatient anticoagulation pharmacy service and hospital reference laboratory. Journal of Thrombosis and Thrombolysis. 42(4). 471–478. 21 indexed citations
11.
Mahan, Charles E.. (2015). Practical aspects of treatment with target specific anticoagulants: initiation, payment and current market, transitions, and venous thromboembolism treatment. Journal of Thrombosis and Thrombolysis. 39(3). 295–303. 8 indexed citations
12.
Mahan, Charles E., Larry E. Fields, Roger M. Mills, et al.. (2015). All-cause mortality and use of antithrombotics within 90 days of discharge in acutely ill medical patients. Thrombosis and Haemostasis. 114(10). 685–694. 2 indexed citations
13.
Mahan, Charles E., et al.. (2014). External validation of a risk assessment model for venous thromboembolism in the hospitalised acutely-ill medical patient (VTE-VALOURR). Thrombosis and Haemostasis. 112(10). 692–699. 69 indexed citations
14.
15.
Mahan, Charles E., Maxine D. Fisher, Roger M. Mills, et al.. (2013). Thromboprophylaxis patterns, risk factors, and outcomes of care in the medically ill patient population. Thrombosis Research. 132(5). 520–526. 44 indexed citations
16.
Burnett, Allison, et al.. (2013). The hidden costs of anticoagulation in hospitalized patients with non-valvular atrial fibrillation. Expert Opinion on Pharmacotherapy. 14(9). 1119–1133. 5 indexed citations
17.
Borrego, Matthew E., et al.. (2012). Venous thromboembolism: Annualised United States models for total, hospital-acquired and preventable costs utilising long-term attack rates. Thrombosis and Haemostasis. 108(8). 291–302. 128 indexed citations
18.
Holdsworth, Mark T., et al.. (2011). Deep-vein thrombosis: A United States cost model for a preventable and costly adverse event. Thrombosis and Haemostasis. 106(9). 405–415. 60 indexed citations
19.
Mahan, Charles E., et al.. (2010). Venous Thromboembolism Prevention: A Systematic Review of Methods to Improve Prophylaxis and Decrease Events in the Hospitalized Patient. Hospital Practice. 38(1). 97–108. 33 indexed citations
20.
Spyropoulos, Alex C. & Charles E. Mahan. (2009). Venous Thromboembolism Prophylaxis in the Medical Patient: Controversies and Perspectives. The American Journal of Medicine. 122(12). 1077–1084. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Allison Burnett Breakdown of academic impact, for papers by Lana A. Castellucci Breakdown of academic impact, for papers by N. Ruiz‐Giménez Breakdown of academic impact, for papers by Esteban Gándara Breakdown of academic impact, for papers by Ricardo Pavanello Breakdown of academic impact, for papers by Cynthia Wu Breakdown of academic impact, for papers by Marica Perlati Breakdown of academic impact, for papers by Michela Giustozzi Breakdown of academic impact, for papers by B. Brandolin Breakdown of academic impact, for papers by Michele G. Beckman
Rankless by CCL
2026